Sabal Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $46M | Sell |
219,450
-1,692
| -0.8% | -$329K | 2.55% | 4 |
|
|
2024
Q4 | $39.3M | Sell |
221,142
-1,000
| -0.5% | -$184K | 2.27% | 6 |
|
|
2024
Q3 | $43.9M | Sell |
222,142
-203
| -0.1% | -$37.9K | 2.39% | 6 |
|
|
2024
Q2 | $38.1M | Sell |
222,345
-6,446
| -3% | -$1.07M | 2.27% | 9 |
|
|
2024
Q1 | $41.7M | Sell |
228,791
-1,767
| -0.8% | -$305K | 2.42% | 6 |
|
|
2023
Q4 | $35.7M | Sell |
230,558
-4,073
| -2% | -$594K | 2.2% | 11 |
|
|
2023
Q3 | $35M | Sell |
234,631
-1,583
| -0.7% | -$232K | 2.34% | 10 |
|
|
2023
Q2 | $31.8M | Buy |
236,214
+54,473
| +30% | +$7.99M | 2.02% | 17 |
|
|
2023
Q1 | $29M | Sell |
181,741
-793
| -0.4% | -$121K | 2.02% | 21 |
|
|
2022
Q4 | $29.5M | Sell |
182,534
-2,732
| -1% | -$419K | 2.01% | 22 |
|
|
2022
Q3 | $24.9M | Buy |
185,266
+7,813
| +4% | +$1.12M | 1.88% | 28 |
|
|
2022
Q2 | $27.2M | Buy |
+177,453
| New | +$27.1M | 1.95% | 23 |
|
|
2022
Q1 | – | Sell |
-172,038
| Closed | -$23.3M | – | 142 |
|
|
2021
Q4 | $23.3M | Buy |
172,038
+163,837
| +1,998% | +$19.4M | 1.48% | 37 |
|
|
2021
Q3 | $885K | Hold |
8,201
| – | – | 0.06% | 82 |
|
|
2021
Q2 | $925K | Sell |
8,201
-141
| -2% | -$15.9K | 0.07% | 75 |
|
|
2021
Q1 | $903K | Buy |
8,342
+20
| +0.2% | +$2.14K | 0.07% | 79 |
|
|
2020
Q4 | $891K | Sell |
8,322
-3,279
| -28% | -$315K | 0.07% | 74 |
|
|
2020
Q3 | $1.02M | Buy |
11,601
+56
| +0.5% | +$5.27K | 0.09% | 71 |
|
|
2020
Q2 | $1.13M | Sell |
11,545
-1,211
| -9% | -$107K | 0.11% | 66 |
|
|
2020
Q1 | $972K | Buy |
12,756
+521
| +4% | +$44.4K | 0.11% | 65 |
|
|
2019
Q4 | $1.08M | Sell |
12,235
-641
| -5% | -$53.2K | 0.09% | 67 |
|
|
2019
Q3 | $975K | Hold |
12,876
| – | – | 0.08% | 73 |
|
|
2019
Q2 | $936K | Sell |
12,876
-1,445
| -10% | -$114K | 0.08% | 70 |
|
|
2019
Q1 | $1.15M | Sell |
14,321
-4,117
| -22% | -$337K | 0.1% | 69 |
|
|
2018
Q4 | $1.7M | Sell |
18,438
-1,244
| -6% | -$109K | 0.17% | 57 |
|
|
2018
Q3 | $1.86M | Sell |
19,682
-270,658
| -93% | -$25.7M | 0.16% | 57 |
|
|
2018
Q2 | $26.9M | Buy |
290,340
+17,473
| +6% | +$1.71M | 2.56% | 13 |
|
|
2018
Q1 | $25.8M | Sell |
272,867
-46,187
| -14% | -$5.07M | 2.47% | 15 |
|
|
2017
Q4 | $30.9M | Sell |
319,054
-26,388
| -8% | -$2.49M | 3.14% | 8 |
|
|
2017
Q3 | $30.7M | Sell |
345,442
-38,151
| -10% | -$2.9M | 3.07% | 5 |
|
|
2017
Q2 | $27.8M | Buy |
383,593
+8,639
| +2% | +$581K | 2.92% | 7 |
|
|
2017
Q1 | $24.4M | Sell |
374,954
-7,995
| -2% | -$503K | 2.73% | 10 |
|
|
2016
Q4 | $24M | Buy |
382,949
+9,644
| +3% | +$589K | 2.62% | 17 |
|
|
2016
Q3 | $23.5M | Sell |
373,305
-7,896
| -2% | -$511K | 2.61% | 16 |
|
|
2016
Q2 | $23.6M | Buy |
381,201
+5,887
| +2% | +$359K | 2.72% | 17 |
|
|
2016
Q1 | $21.4M | Buy |
+375,314
| New | +$20.9M | 2.54% | 19 |
|
|
2015
Q4 | – | Sell |
-369,049
| Closed | -$20.1M | – | 123 |
|
|
2015
Q3 | $20.1M | Sell |
369,049
-23,978
| -6% | -$1.56M | 2.81% | 17 |
|
|
2015
Q2 | $26.4M | Sell |
393,027
-2,494
| -0.6% | -$163K | 3.44% | 3 |
|
|
2015
Q1 | $23.2M | Buy |
395,521
+7,285
| +2% | +$440K | 3.04% | 8 |
|
|
2014
Q4 | $25.4M | Sell |
388,236
-17,973
| -4% | -$1.13M | 3.29% | 2 |
|
|
2014
Q3 | $23.5M | Buy |
+406,209
| New | +$22.6M | 3.15% | 6 |
|
|
2014
Q2 | – | Sell |
-398,922
| Closed | -$20.5M | – | 104 |
|
|
2014
Q1 | $20.5M | Sell |
398,922
-21,364
| -5% | -$1.08M | 2.9% | 11 |
|
|
2013
Q4 | $22.2M | Buy |
420,286
+229
| +0.1% | +$11.3K | 3.16% | 7 |
|
|
2013
Q3 | $18.8M | Buy |
420,057
+493
| +0.1% | +$21.9K | 2.92% | 8 |
|
|
2013
Q2 | $17.3M | Buy |
+419,564
| New | +$18.3M | 2.77% | 8 |
|
Other funds holding ABBV
Sabal Trust's ABBV Position: Q1 2025 in Review
Sabal Trust reduced its AbbVie (ABBV) stake by 0.77% in Q1 2025, selling an estimated $329K and leaving 219,450 shares worth $46M. The position accounts for 2.55% of the portfolio, ranked #4.
Sabal Trust first reported a position in ABBV in Q2 2013 and has held it in 45 quarters since. 3,820 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.
- Sabal Trust held 219,450 shares of AbbVie worth $46M as of Q1 2025.
- Sabal Trust sold 1,692 AbbVie shares in Q1 2025, an estimated $329K.
- AbbVie made up 2.55% of Sabal Trust's portfolio in Q1 2025, its #4 holding.
- Sabal Trust first reported a position in AbbVie in Q2 2013 and has held it in 45 quarters since.
- 3,820 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.
Based on Sabal Trust's 13F filing for Q1 2025, filed 23 Apr 2025.